PLGA 미립구를 이용한 새로운 단회 접종 항원 전달 시스템의 개발 = Improved Antigen Delivery Systems with PLGA Microsphere for a Single-Step Immunization

다국어 초록 (Multilingual Abstract)

A promising approach to the development of a new single-step vaccine, which would eliminate the requirement for multiple injections, involves the encapsulation of antigens into microspheres. Biodegradable poly (lactide-co-gly-colide) (PLGA) microspheres gave us a bright insight for controlling antigen release in a pulsatile fashion, thereby mimicking two or three boosting injections. However, in spite of the above merits, the level of immunization induced by a single-shot vaccination is often lower than two doses of alum-adsorbed antigen. Therefore, optimal modification of the micorsphere is essential for the development of single-step vaccines. In this review, we discuss the stability of antigen in microsphere, safety and non-toxic in human and encapsulation technology. Also, we attempted to outline relevant physicochemical properties on the immunogenicity of microsphere vaccine and attainment of pulsatile release pattern by combination of different microsphere, as well as to analyze immunological data associated with antigen delivery by microsphere. Although a lot of variables are related to the optimized micorsphere formulation, we could conclude that judicious choice of proper polymer type, adjustment of particles size, and appropriate immunization protocol along with a suitable adjuvant might be a crucial factor for the generation of long-lasting immune response from a single-step vaccine formulation employing PLGA microsphere.

참고문헌 (Reference)

1 "route of elimination and ultra structure of the implant site of polylactic acid in abdominal wall of the rat" 7 : 155-173, 1973

2 "polymeric, microparticle-based vaccines: he influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen" 14 : 1429-1438, 1996

3 "Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers" 18 : 1495-1505, 200

4 "Vaccine delivery to animals" 38 : 167-194, 1999

5 "Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres" 19 : 1047-1054, 2001

6 "The use of bioadhesives in targeted delivery within the gastrointestinal tract" 11 : 221-251, 1993

7 "The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol" 17 : 512-529, 1999

8 "The preparation characterization and pre-clinical evaluation of an orally administered HIV-1 vaccine consisting of a branched peptide immunogen entrapped in controlled release microparticles" 36 : 75-84, 1995

9 "The immune response to a model antigen associated with PLG microparticles prepared using different surfactants" 15 : 1888-1897, 1997

10 "The encapsulation of a model protein in poly(lactide-co-glycolide) microparticles of various sizes: an evaluation of process reproducibility" 14 : 197-203, 1997

11 "The degradation of poly and their copolymers in vivo" 215-224, 1981

12 "The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method" 52 : 311-320, 1998

13 "Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)-and ABA-triblock-copolymers:immune response in mice" 234 : 75-90, 2002

14 "Tetanus toxoid loaded preformed microspheres of crossed linked dextran" 19 : 3853-3859, 2001

15 "Tetanus toxoid loaded nanoparticles from sulfobutylated poly(Vinyl Alcohol)-graft-poly(lactide-co-glycolide) Evaluation of antibody response after oral and nasal application in mice" 18 : 352-360, 2001

16 "Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) micro- spheres : Importance of polymer degradation and antigen release for immune response" 41 : 131-145, 1996

17 "Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity" 14 : 1523-1530, 1996

18 "Synthetic delivery system for tuberculosis vaccines immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biode- gradable PLGA microparticles" 13 : 1576-1582, 1995

19 "Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly A-blocks attached to central poly" 247-257, 1993

20 "Sustained release of human growth hormone from microcapsules prepared by a solvent evaporation technique" 88 : 229-242, 2003

21 "Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines" 18 : 2592-2599, 2000

22 "Stable formulations of recombinant human growth hormone and interferon for microencapsulation in biodegradable microspheres" 13 : 1464-1475, 1996

23 "Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen," 85 : 129-132, 1996

24 "Size effect on the antibody production induced by biodegradable micro- spheres containing antigen" 14 : 1251-1256, 1996

25 "Single shot vaccine with tetanus toxoid in biodegradable microsphere protects mice despite acid-induced denaturation of the antigen" 14 : 1627-1632, 1996

26 "S.S. Davis and S.J. Challacombe" immunology : 73-, 239-242

27 "Revisiting PLA/PLGA microspheres:An analysis of their potential in parenteral vaccination" 50 : 129-146, 2000

28 "Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunization of SPf66 encapsulated in PLGA microspheres" 20 : 1707-1710, 2002

29 "Release of tetanus toxoid from adjuvants and PLGA microspheres:How experimental set-up and surface adsorption fool the pattern" 56 : 209-217, 1998

30 "Receptor-mediated targeting of spray-dried lipid particles co-formulated with immunoglobulin and loaded with a prototype vaccine" 18 : 971-979, 2001

31 "Recent advances in vaccine adjuvants:The development of MF59 emulsion and polymeric microparticles" 3 : 69-75, 1997

32 "Recent advances in vaccine adjuvants" 19 : 715-728, 2002

33 "Quantitation of specific antibodies Methods of expression In Immunochemistry of Solid-phase Imunoassays" CRC Press 173-198, 1991

34 "Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems" 49 : 13-19, 1995

35 "Problems associ- ated with preparative techniques and release properties" 297-325, 1990

36 "Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines" 18 : 238-250, 1999

37 "Porous chitosan microsphere for controlling the antigen release of Newcastle disease vaccine:preparation of antigen-adsorbed microsphere and in vitro release" 20 : 1603-1612, 1999

38 "Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines" 32 : 225-246, 1998

39 "Poly(DL-lactide-co-glycolide) microspheres as carriers for peptide vaccines" 14 : 879-885, 1996

40 "Poly (lactide-co-glycolide) microencapsulation of vaccine antigens" 44 : 29-36, 1996

41 "Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro" 14 : 1205-1213, 1996

42 "Particle size control of poly(lactide-co-glycolide) micro- spheres for oral antigen delivery system," 315-321, 1999

43 "Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly (ethylene oxide) B blocks" 39 : 315-326, 1996

44 "Parameters influencing the antigen release from spray-dried poly" 200 : 133-145, 2000

45 "Oral vaccination with alginate microsphere systems" 39 : 209-220, 1996

46 "OHagan and K.H. Mills, Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells" 13 : 1741-1749, 1995

47 "New advances in microsphere-based single-dose vaccines" 28 : 97-119, 1997

48 "Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccine virus Ankara" 313 : 13-21, 2003

49 "Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres" 92 : 259-267, 1998

50 "Microparticles in MF59 a potent adjuvant combination for a recombinant protein vaccine against HIV-1" 18 : 1793-1801, 2000

51 "Long term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles" 11 : 965-969, 1993

52 "Liposomes as carriers of antigens and adjuvants" 140 : 1-13, 1991

53 "Liposomes as carrier and immunoadjuvant of vaccine antigens" 13 : 255-279, 1990

54 "Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid" 14 : 1031-1038, 1996

55 "Induction of mucosal and systemic immune responses by immunization with albumin entrapped in poly" immu (immu): 661-667, 1994

56 "In vivo distribution of radioactivity in micea after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid" 14 : 1414-1416, 1996

57 "In fluence of formulation variables on the morphology of biodegradable microparticles prepared by spray-drying" 24 : 169-174, 1998

58 "Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives" 15 : 1103-1110, 1998

59 "Improved immunogenicity of a core-coated tetanus toxoid delivery system" 18 : 618-622, 2000

60 "Improved immune response from biodegradable polymer particle entrapping tetanus toxoid by use of different immunization protocol and adjuvants" 245 : 109-121, 2002

61 "Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation on protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres" 221-235, 1995

62 "Immunopotentiation and delivery systems for antigens for single-step immunization:Recent trends and progress" 11 : 2-10, 1994

63 "Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs" 28 : 209-215, 2000

64 "Immunogenicity and protection in small animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine" 1716-1721, 1997

65 "Immune responses to V antigen of Yersinia pestis co-encapsulated with IFN-:Effect of dose and formulation" 16 : 517-521, 1998

66 "Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66" 260 : 273-282, 2003

67 "Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres" 185 : 255-266, 1999

68 "Formulation and characterization of immunoreactive tetanus toxoid biodegradable polymer particles" 8 : 99-106, 2001

69 "Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres" 24 : 57-65, 1996

70 "Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents" 15 : 1111-1116, 1998

71 "Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres" 56 : 56-73, 1998

72 "Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres con- taining ovalbumin" 23 : 385-390, 2000

73 "Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA-PLGAs" 47 : 193-201, 1999

74 "Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosi" 242 : 341-344, 2002

75 "Determination of protein loading in biodegradable polymer microspheres containing tetanus toxoid" 15 : 672-678, 1997

76 "Determinants of release rate of tetanus vaccine from polyester microspheres" 10 : 945-953, 2003

77 "Controlled release of bioactive agents from lactide/glycolide polymers In Biodegradable Polymers as Drug Delivery System" 9-41, 1990

78 "Controlled release microparticles for vaccine development" 9 : 768-771, 1991

79 "Controlled release microparticles as a single dose hepatitis B vaccine Evaluation of immuno- genicity in mice" 15 : 475-481, 1997

80 "Controlled release microparticles as a single dose diphtheria toxoid vaccine Immunogenicity in small animal models" 16 : 346-352, 1998

81 "Controlled delivery systems for protein based on poly" 713-720, 1991

82 "Controlled delivery of diphtheria toxoid using biodegradable poly" 958-961, 1991

83 "Comparison of inactivated Newcastle disease viral vaccines containing different emulsion adjuvants" 44 : 72-75, 1983

84 "Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines" 19 : 694-705, 2001

85 "Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid" 19 : 3091-3096, 2001

86 "Chronic local tissue reactions, long term immuno- genicity and immunologic proming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide poly- mers" 15 : 1716-1723, 1997

87 "Cholera toxin B subunit retains antigenicity and immuno- genicity following encapsulation in biodegradable micro- particles" 119 : 251-255, 1995

88 "CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles" 206 : 143-151, 1997

89 "Biodegradable polymers: In Controlled and Novel Drug Delivery, N.K. Jain (Ed.)" CBS Publishers and Distributors 27-51, 1997

90 "Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments" 18 : 1153-1161, 1997

91 "Biodegradable polymer microspheres as vaccine adjuvants and delivery systems" 92 : 63-78, 1998

92 "Biodegradable microspheres for protein delivery" 90 : 261-280, 2003

93 "Biodegradable microspheres containing influenza A vaccine: Immune response in mice" 17 : 1065-1073, 1999

94 "Biodegradable microparticles with an entrapped branched octameric peptide as a controlled-release HIV-1 vaccine" 86 : 1229-1233, 1997

95 "Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens" 242 : 15-24, 2002

96 "Antibody-directed liposomes as drug delivery vehicles" 3 : 343-389, 1989

97 "Ambiguities in the preclinical quality assessment of microparticulate vaccines" 18 : 203-211, 2000

98 "Adjuvant activity of a novel metabolizable lipid emulsion with inactivated viral vaccines" 28 : 937-943, 1980

99 "A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide" 13 : 683-689, 1995

100 "A novel microencapsulated peptide vaccine against hepatitis B" 19 : 3292-3300, 2001

101 "A novel emulsification-solvent extraction technique for produc-tion of protein loaded biodegradable microparticles for vaccine and drug delivery" 33 : 437-445, 1995

102 "A new technique to efficiently entrap leuprorelide acetate into microcapsules of poly" 1095-1108, 1988

103 "A new absorbable study" 1 : 43-52, 1971